Tecon Pharmaceutical
Develops epidemic vaccines for major livestock and poultry, enabling farmers to prevent animal diseases
About Tecon Pharmaceutical
TECON Pharmaceutical Co., Ltd. is a Chinese national high-tech enterprise integrating R&D, production and sales of veterinary vaccines, diagnostic reagents, and animal disease prevention-and-control solutions. Founded on a 67-year legacy, the company operates five intelligent manufacturing parks custom-built for animal vaccines, equipped with 26 GMP production lines, and holds 29 new veterinary drug registration certificates and 194 authorized patents. It leads the Chinese market share in major animal disease vaccines and zoonotic disease vaccines: its foot-and-mouth disease and avian influenza vaccines are benchmarks of cell-suspension manufacturing technology in China, while its swine and ruminant vaccines rank among the top domestically. The company serves agricultural enterprises, veterinarians, and farming customers across livestock and poultry segments, helping ensure herd health and biosecurity, and is actively expanding global product-agent and production-technology partnerships.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- China
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
China Capital Management Company- XCXinjiang Production and Construction Corps
- XFXinjiang Huyang Fund
Yuanfeng Capital
Shenzhen Capital Group- YCYuanchuang Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tecon Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tecon Pharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.